Showing 1 - 20 results of 4,920 for search '(( i large decrease ) OR ((( _ largest decrease ) OR ( 6 ((step decrease) OR (we decrease)) ))))', query time: 0.66s Refine Results
  1. 1
  2. 2
  3. 3

    Image 1_Exploration of the diagnostic and prognostic roles of decreased autoantibodies in lung cancer.tif by Ying Ye (72583)

    Published 2025
    “…</p>Methods<p>In this study, we applied the HuProt array and the bioinformatics analysis to assess the diagnostic values of the decreased autoantibodies in lung cancers.…”
  4. 4

    Table 1_Effect of decreased suspended sediment content on chlorophyll-a in Dongting Lake, China.docx by Le Zhang (88249)

    Published 2025
    “…However, the effect of reduced SSC on Chl-a is poorly studied. Here, we compared and analyzed the distribution conditions of Chl-a in 6 representative years for both before the implementation of Three Gorges Dam (TGD) (BIT) and after the implementation of TGD (AIT), using the TM/OLI data and NIR-red inversion model. …”
  5. 5
  6. 6
  7. 7

    Algorithm operation steps. by Junyan Wang (4738518)

    Published 2025
    “…Experimental results demonstrate that SCI-YOLO11 achieves a 3.2% improvement over baseline models in terms of MAP@0.5 metric; precision and recall rates increase by 2.6% and 3.7%, respectively. Additionally, its parameter count and floating-point operations decrease by 6% and 7.9%, respectively. …”
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    Conformational Role of Methyl in the Potency of Cyclohexane-Substituted Squaramide CCR6 Antagonists by Brian S. Gerstenberger (1936534)

    Published 2025
    “…Herein we report the design of a potent CCR6 antagonist capable of inhibiting the chemotactic migration of CCR6<sup>+</sup> T cells in vitro. …”
  17. 17

    Conformational Role of Methyl in the Potency of Cyclohexane-Substituted Squaramide CCR6 Antagonists by Brian S. Gerstenberger (1936534)

    Published 2025
    “…Herein we report the design of a potent CCR6 antagonist capable of inhibiting the chemotactic migration of CCR6<sup>+</sup> T cells in vitro. …”
  18. 18

    Conformational Role of Methyl in the Potency of Cyclohexane-Substituted Squaramide CCR6 Antagonists by Brian S. Gerstenberger (1936534)

    Published 2025
    “…Herein we report the design of a potent CCR6 antagonist capable of inhibiting the chemotactic migration of CCR6<sup>+</sup> T cells in vitro. …”
  19. 19
  20. 20